Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Esketamine, a molecular relative of regular ... the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without ...
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...
Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they ...